1. Combining Dinutuximab with ALT-803 (IL-15 Superagonist) Significantly Improves the Activity of Ex Vivo Expanded Natural Killer Cells Against GD2+ Pediatric Solid Tumors (ST) 
Gaurav Nayyar, Yaya Chu, Nang Kham Su, Jeremy Rosenblum, Hing C. Wong, Dean Lee, Mitchell S. Cairo 
Biology of Blood and Marrow Transplantation 
Volume 24, Issue 3, Pages S472-S473 (March 2018)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1
Combination of ALT803 with Dinutuximab significantly enchanced the in vitro cytotoxicity against GD2+ OS, NB and GBM.
Biology of Blood and Marrow Transplantation  , S472-S473DOI: ( /j.bbmt )
Copyright © Terms and Conditions